Argel Baltazar
Gerontology · Cedar Grove, NJNPI 1366995128
Payments from drug & device makers
Across 70 payments — averaging $27.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$511
- Novo Nordisk$172
- AstraZeneca$170
- Pfizer$117
- Merck$112
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$111
- plus $731 from 18 others
What the payments were for
- Food & beverage$1,923100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,923 in reported general payments places this provider in the 80th percentile of 374 gerontology providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 225 | $248,966 |
| XareltoRivaroxaban | 66 | $75,877 |
| EntrestoSacubitril/Valsartan | 66 | $72,671 |
| FarxigaDapagliflozin Propanediol | 18 | $23,411 |
| JardianceEmpagliflozin | 22 | $22,193 |
| Repatha SureclickEvolocumab | 27 | $21,759 |
| BrilintaTicagrelor | 13 | $16,027 |
| MultaqDronedarone Hcl | 12 | $14,111 |
| Ranolazine ErRanolazine | 14 | $4,227 |
| EdarbyclorAzilsartan Med/Chlorthalidone | 11 | $3,834 |
| Metoprolol Succinate | 202 | $3,017 |
| Atorvastatin Calcium | 251 | $2,748 |
| Ezetimibe | 73 | $2,173 |
| Rosuvastatin Calcium | 135 | $2,118 |
| Valsartan | 50 | $1,937 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $117 | $248,966225 claims |
| NovartisEntresto | $84 | $72,67166 claims |
| AstraZenecaFarxiga, Brilinta | $170 | $39,43831 claims |
| Boehringer IngelheimJardiance | $16 | $22,19322 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 374 gerontology providers in New Jersey.
Other gerontology in Cedar Grove
- Lisa MalakToms River$162K
- Dana JonesTeaneck$150K
- Jennifer FoxFlemington$76K
- Susan HermidaBrick$33K
- Jihane SaadeNorth Bergen$9K
- Joseph RudolphCamden$8K
- Jennifer LernerNew Brunswick$7K
- Josephine MachadoNew Brunswick$7K
- Remya JamesNew Brunswick$7K
- Anna HaEnglewood$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.